Immuno-Biological Laboratories Co., Ltd. (TYO:4570)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Antibody Related Business	1.00B	964.37M	812.85M	790.60M	637.47M
Cosmetics Related	2.68M	5.16M	3.85M	4.02M	13.35M
Unallocated Adjustment	-	-	-	-	-3.24M
Total	1.00B	969.53M	816.70M	794.62M	647.58M

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
United States	180.37M	196.74M	122.92M	131.49M	74.40M
Japan	593.22M	589.36M	549.71M	537.89M	490.31M
Others	139.10M	114.98M	84.66M	63.81M	33.12M
China	92.30M	68.46M	59.41M	-	-
Germany	-	-	-	61.44M	49.75M
Total	1.00B	969.53M	816.70M	794.62M	647.57M

Data Source: S&P Global Market Intelligence Last updated: Aug 7, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 3, 2026

Data Sources Report a data error